CorMedix Statistics

Total Valuation

CorMedix has a market cap or net worth of $291.05 million. The enterprise value is $206.29 million.

Market Cap	291.05M
Enterprise Value	206.29M

Important Dates

The next estimated earnings date is Monday, May 13, 2024, after market close.

Earnings Date	May 13, 2024
Ex-Dividend Date	n/a

Share Statistics

CorMedix has 54.81 million shares outstanding. The number of shares has increased by 26.39% in one year.

Shares Outstanding	54.81M
Shares Change (YoY)	+26.39%
Shares Change (QoQ)	+1.61%
Owned by Insiders (%)	1.01%
Owned by Institutions (%)	34.12%
Float	54.43M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.02
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.97, with a Debt / Equity ratio of 0.01.

Current Ratio	6.97
Quick Ratio	n/a
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,350.16

Financial Efficiency

Return on equity (ROE) is -72.30% and return on invested capital (ROIC) is -69.14%.

Return on Equity (ROE)	-72.30%
Return on Assets (ROA)	-64.00%
Return on Capital (ROIC)	-69.14%
Revenue Per Employee	n/a
Profits Per Employee	-$565,113
Employee Count	82
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +10.90% in the last 52 weeks. The beta is 1.89, so CorMedix's price volatility has been higher than the market average.

Beta (1Y)	1.89
52-Week Price Change	+10.90%
50-Day Moving Average	4.20
200-Day Moving Average	3.76
Relative Strength Index (RSI)	57.08
Average Volume (30 Days)	613,658

Short Selling Information

The latest short interest is 9.38 million, so 17.11% of the outstanding shares have been sold short.

Short Interest	9.38M
Short Previous Month	8.25M
Short % of Shares Out	17.11%
Short % of Float	17.23%
Short Ratio (days to cover)	12.43

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-48.96M
Pretax Income	-46.34M
Net Income	-46.34M
EBITDA	-46.23M
EBIT	-46.30M
Earnings Per Share (EPS)	-$0.91

Full Income Statement

Balance Sheet

The company has $76.11 million in cash and $667,632 in debt, giving a net cash position of $75.44 million or $1.38 per share.

Cash & Cash Equivalents	76.11M
Total Debt	667,632
Net Cash	75.44M
Net Cash Per Share	$1.38
Equity / Book Value	70.14M
Book Value Per Share	1.28
Working Capital	68.05M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$38.41 million and capital expenditures -$327,300, giving a free cash flow of -$38.74 million.

Operating Cash Flow	-38.41M
Capital Expenditures	-327,300
Free Cash Flow	-38.74M
FCF Per Share	-$0.76

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CorMedix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-26.39%
Shareholder Yield	-26.39%
Earnings Yield	-16.45%
FCF Yield	-13.75%

Analyst Forecast

The average price target for CorMedix is $13.00, which is 144.82% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.00
Price Target Difference	144.82%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on March 26, 2019. It was a reverse split with a ratio of 1:5.

Last Split Date	Mar 26, 2019
Split Type	Reverse
Split Ratio	1:5

Scores

Altman Z-Score	n/a
Piotroski F-Score	2